SEYTRI-T 1.125 VAIL

Seytri-T 1.125 Vial (1×1 Vial)
Product Overview

Seytri-T 1.125 Vial is a broad-spectrum antibiotic injection formulated to combat a wide range of bacterial infections. It combines the powerful action of Ceftriaxone (1 g) and Tazobactam (125 mg) to deliver effective treatment against both gram-positive and gram-negative bacteria. This combination helps manage infections of the lungs, urinary tract, skin, soft tissues, abdomen, bones, joints, and reproductive system, as well as severe infections like meningitis and septicemia.

How It Works

This dual-action antibiotic works by inhibiting bacterial cell wall synthesis through Ceftriaxone, leading to the destruction of harmful microorganisms. Tazobactam enhances this effect by blocking beta-lactamase enzymes, which protect bacteria from antibiotic action. Together, they ensure stronger and longer-lasting antibacterial protection while minimizing the risk of resistance.

Key Benefits

Provides powerful protection against a wide range of bacterial infections

Combines two active ingredients for enhanced effectiveness

Helps prevent infection recurrence and bacterial resistance

Offers quick relief from infection-related symptoms such as fever, pain, and inflammation

Suitable for hospital-acquired and community-acquired infections

Administered under medical supervision for safe and precise dosage

Uses of Seytri-T 1.125 Vial

Respiratory infections (pneumonia, bronchitis)

Urinary tract infections (UTIs)

Skin and soft tissue infections

Bone and joint infections

Intra-abdominal and pelvic infections

Septicemia and meningitis

Post-surgical or wound infections

Dosage and Administration

Seytri-T 1.125 Vial is intended for intravenous (IV) or intramuscular (IM) administration and should be given only by a healthcare professional. The dosage and duration are determined by the doctor based on the infection type, severity, and patient’s health status. It is important to complete the full course as prescribed to ensure full recovery and prevent the development of antibiotic resistance.

Possible Side Effects

While Seytri-T 1.125 is generally well tolerated, some individuals may experience mild or temporary effects such as:

Pain or swelling at the injection site

Nausea or vomiting

Diarrhea

Skin rash or itching

Headache or dizziness

In rare cases, serious allergic reactions may occur. Seek immediate medical help if you experience difficulty breathing, swelling, or severe skin reactions.

Safety & Precautions

Prescription Required: Use only under medical guidance.

Alcohol: Avoid alcohol during treatment to reduce unwanted side effects.

Pregnancy & Breastfeeding: Consult your doctor before use.

Kidney or Liver Impairment: Dose adjustments may be needed; medical monitoring is advised.

Driving: If you feel dizzy or unwell after injection, avoid driving or operating heavy machinery.

Hydration: Maintain adequate fluid intake to support recovery and medication effectiveness.

Storage Instructions

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use if the vial appears damaged or past the expiry date.

Why Choose Seytri-T 1.125 Vial

Trusted antibiotic combination for comprehensive infection control

Clinically proven formula for rapid bacterial elimination

Manufactured under strict pharmaceutical standards to ensure safety and efficacy

Reliable choice for healthcare professionals and hospitals

Product Variants & Keywords

Seytri-T 1.125 Vial | Seytri T Injection | Seytri T 1.125 IV | Seytri-T 1.125 Antibiotic | Seytri T Ceftriaxone and Tazobactam Injection | Seytri-T 1.125 gm Vial | Seytri T 1.125 mg | Seytri T Injection 1g + 125mg